TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/21 09:11 | 8/16/21 | PHIO | Phio Pharmaceuticals Corp. | DE | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | DO | P,CEO | P | 10 | 1.63 | 0 | 6 | 7 | 95 | D | ||||||||||||||
3/5/21 07:05 | 3/4/21 | PHIO | Phio Pharmaceuticals Corp. | DE | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | DO | P,CEO | P | 5 | 2.56 | 0 | 2 | 2 | 89 | D | ||||||||||||||
3/3/21 21:00 | 3/3/21 | PHIO | Phio Pharmaceuticals Corp. | DE | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | DO | P,CEO | P | 8 | 3.03 | 0 | 3 | 3 | 87 | D | ||||||||||||||
8/19/20 17:00 | 8/19/20 | PHIO | Phio Pharmaceuticals Corp. | DE | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | O | P,CEO | P | 5 | 2.50 | 0 | 2 | 14 | 16 | D | ||||||||||||||
6/26/17 08:23 | 6/23/17 | RXII | Rxi Pharmaceuticals Corp | DE | Health | Drug | Pharmaceutical Preparations | Dispersyn Gerrit | MA | O | Chief De | P | 2 | 0.6200 | 0 | 4 | New | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |